Developments in the diagnostic procedures for von Willebrand disease.

作者: A. De Jong , J. Eikenboom

DOI: 10.1111/JTH.13243

关键词:

摘要: Von Willebrand disease (VWD) is the most common inherited bleeding disorder but its diagnosis can be challenging due to heterogeneity of disease. VWD mainly associated with mild mucocutaneous bleeding, although there are more severe phenotypes from gastrointestinal tract or even joints. Also, surgical interventions and trauma may lead critical events. These episodes all related quantitative qualitative defects von factor (VWF), a multimeric glycoprotein produced by endothelial cells megakaryocytes, which mediates platelet adhesion aggregation binds VIII (FVIII) in circulation. This review describes diagnostic procedures required for correct diagnosis. Accurate classification proper treatment counseling. Assessment starts medical history. After positive family history, subsequent laboratory investigations will start panel standard screening tests hemostatic defects. Patients suspected having tested plasma VWF antigen levels, ability bind platelets FVIII activity. When confirmed, set subtyping classify patients as types 1, 2 (A, B, M N) 3. The performance some additional assays analyses, such propeptide measurement genetic analysis, help identifying pathological mechanism behind certain guide choice treatment.

参考文章(90)
Paul J Murdock, Barry J Woodhams, Kathy B Matthews, K John Pasi, Alison H Goodall, von Willebrand factor activity detected in a monoclonal antibody-based ELISA: an alternative to the ristocetin cofactor platelet agglutination assay for diagnostic use. Thrombosis and Haemostasis. ,vol. 78, pp. 1272- 1277 ,(1997) , 10.1055/S-0038-1657727
F Rodeghiero, G Castaman, E Dini, Epidemiological Investigation of the Prevalence of von Willebrand's Disease Blood. ,vol. 69, pp. 454- 459 ,(1987) , 10.1182/BLOOD.V69.2.454.454
Sourav Kundu, Eric Heilmann, Reynaldo Sio, Carmen Garcia, Rosa Davidson, Roy Ostgaard, Description of an in vitro platelet function analyzer--PFA-100. Seminars in Thrombosis and Hemostasis. ,vol. 21, pp. 106- 112 ,(1995) , 10.1055/S-0032-1313612
AJ Vlot, SJ Koppelman, MH van den Berg, BN Bouma, JJ Sixma, The affinity and stoichiometry of binding of human factor VIII to von Willebrand factor Blood. ,vol. 85, pp. 3150- 3157 ,(1995) , 10.1182/BLOOD.V85.11.3150.BLOODJOURNAL85113150
F I Pareti, K Niiya, J M McPherson, Z M Ruggeri, Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III. Journal of Biological Chemistry. ,vol. 262, pp. 13835- 13841 ,(1987) , 10.1016/S0021-9258(19)76501-6
M. Deforest, J. Grabell, S. Albert, J. Young, A. Tuttle, W. M. Hopman, P. D. James, Generation and optimization of the self‐administered bleeding assessment tool and its validation as a screening test for von Willebrand disease Haemophilia. ,vol. 21, ,(2015) , 10.1111/HAE.12747
JC Gill, J Endres-Brooks, PJ Bauer, WJ Jr Marks, RR Montgomery, The effect of ABO blood group on the diagnosis of von Willebrand disease Blood. ,vol. 69, pp. 1691- 1695 ,(1987) , 10.1182/BLOOD.V69.6.1691.1691
A. TOSETTO, G. CASTAMAN, I. PLUG, F. RODEGHIERO, J. EIKENBOOM, Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation Journal of Thrombosis and Haemostasis. ,vol. 9, pp. 1143- 1148 ,(2011) , 10.1111/J.1538-7836.2011.04265.X
Ramses F. J. Kemperman, Hanneke C. Kluin-Nelemans, André B. Mulder, Karina Meijer, H. Knol, Haemostatic variables during normal menstrual cycle. A systematic review. Thrombosis and Haemostasis. ,vol. 107, pp. 22- 29 ,(2011) , 10.1160/TH11-07-0481